Drug Approval | November 11, 2024
Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Q2 FY25 Total Income was at Rs. 85.4 crore
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
_256_384.jpg)
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
This product will be manufactured at Lupin’s Nagpur facility in India
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
Max Healthcare Institute has reported total income of Rs. 1,748.30 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
